Arrow Global is strengthening its servicing offering in Germany by acquiring a local real estate developer in a deal expected to help the firm’s regional expansion in servicing and equity investments. Read...
Read MoreBiolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into programmable, intelligent medicines, today announced that it has entered into a multi-target drug discovery collaboration with Merck KGaA, Darmstadt, Germany. The partnership will leverage Biolojic Design’s AI-driven discovery platform to design therapeutic antibodies for the treatment of cancer and immunological disorders. Read...
Read MoreOver the last 12 to 18 months, we have witnessed a meaningful decline in private equity (PE) exits, which triggered an estimated $106 billion of net cash outflows for PE investors in 2022 alone.1 In our view, this dynamic—combined with the denominator effect and generally elongating holding periods—is opening attractive opportunities for providers of liquidity to the private markets. Read more...
Read MoreOncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a research study with Dana-Farber Cancer Institute, a world leader in adult and pediatric cancer treatment and research, to identify biomarkers for renal cell carcinoma (RCC), a type of kidney cancer. Read more...
Read MoreSammy Rubin, founder and CEO of YuLife, the lifestyle insurance company providing life insurance, well-being and rewards in one simple app. Read...
Read More
